Poster session: Oncology: basic research

	Poster Interaction and Discussion Bridge / Foyer 87
4th European Congress of Oto-Rhino-Laryngology, Head and Neck Surgery

Oncology: basic research - experimental

Poster should stay in place during the entire congress.
The author or co-author is kindly asked to be present at the following special times:

Even poster numbers: Sunday May 14, 2000 10.30 a.m. - 11.00 a.m.

Monday May 15, 2000 10.30 a.m. - 11.00 a.m.

Tuesday May 16, 2000 10.30 a.m. - 11.00 a.m.

Wednesday May 17, 2000 10.30 a.m. - 11.00 a.m.

Uneven poster numbers: Sunday May 14, 2000 4.00 p.m. - 4.30 p.m.

Monday May 15, 2000 4.00 p.m. - 4.30 p.m.

Tuesday May 16, 2000 4.00 p.m. - 4.30 p.m.

Thursday May 18, 2000 10.30 a.m. - 11.00 a.m.

Number
Title, Author

1432 The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus oncoprotein latent membrane protein 1
H. Takeshita, M. Furukawa, T. Yoshizaki, Kanazawa, Ishikawa/Japan

1433 Increased levels of urokinase receptor in plasma of head and neck squamous cell carcinoma patients
M. Schmidt, F. Hoppe, Würzburg/Germany

1434 Immunostaining of nm23 and p53 antigens in metastasizing and nonmetastasizing laryngeal cancer
T. Krecicki, D. Ous, J. Kozlak, Zalesska-Krecicka, Wroclaw/Poland

1435 Telomerase activity in head and neck squamous cell carcinoma
C. Motsch, R.Schneider-Stock, Magdeburg/Germany

1436 Ultrastructural expression of E-cadherin in squamous cell carcinomas and cell lines
Th. Stange, Th. Schrom, A. Berghaus, H.-J. Holzhausen, Halle /Germany

1437 Model for testing of cytostatic effects of different agents under hypoxic conditions on ENT-relevant tumor cells
D.Matschiner, M. Bloching, H. Liedtke, Th. Stange, Halle/Germay

1438 Cytokine release of immune cells following stimulation with bispecific antibody BIU I
A.Walz, R.Zeidler, B.Schmitt, H.Lindhofer, et al., Munich/Germany

1439 Genotoxicity of DI- and DIISO-Butylphthalates in human mucosal cells and lymphocytes
B.C. Wallner, N. H. Kleinsasser, A. Bergner, U.A. Harréus, Munich/Germany

1440 Telomerase activity and inactivation of the tumor suppressor gene P16 (CDKN2A) in head and neck cancer
S. Koscielny, R. Dahse, E. Beleites, W. Fiedler, Jena/Germany

1441 Prognostic significance of neovascularisation in laryngeal cancer
W. Pietruzewska, H. Niewiadomska, M. Gryczynski, Lodz/Poland

1442 Expression of p53 and bcl-2 proteins in laryngeal cancer
W. Pietruszewska, J. Kobos, M. Gryczynski, Lodz/Poland

1443 Is there an influence of ML-1 standardized mistletoe extract on IL-10 and IL-12 in patients with head and neck cancer?
C. Fauser, M.K. Steuer-Vogt, R. Sedlmeier, V. Bonkowsky, Munich/Germany

1444 Human papillomavirus infection in the laryngeal carcinoma
W. Makowska, E. Bogacka-Zatorska, T. Rogozinski, Warsaw/Poland

1445 Improved determination of carboplatin and docetaxel cytotoxicity
R. Dollner, A. Dietz, H. Weidauer, C. Granzow, Heidelberg/Germany

1446 Apoptosis expression of P21 and P27 as a prognosis of squamous cell carcinoma of head and neck
E.T. Becker, I. Wiest, M. K. Steuer-Vogt, H. P. Niedermeyer, Munich/Germany

1447 Syndecan-1 expression in laryngeal cancer
J. Klatka, D. Skomra, W. Golabek, S. Klonowski, Lublin/Poland

1448 The expression of Ki 67 antigen in tracheal mucosa of patients with laryngeal malignomas
D. Manestar, R. Starcevic, D. Kovac, I. Lustica, Rijeka/Croatia

1449 P53 allelic loss and the outcome of patients with squamous cell carcinoma of the head and neck
C. Suarez, J. P. Rodrigo, V. Alvarez, Oviedo/Spain

1450 Evaluation of the activity of kininogene and kinins receptors in precancerous conditions as well in the head and neck area malignant neoplasms
M. Kapral, U. Mazurek, T. Gierek, J. Pilch, Sosnowiec/Poland

1451 Antioxidant enzymatic activity in blood of patients with chronic hypertrophy of ORL organs and carcinoma of larynx
P. Zalewski, J. Olszewski, J. Blaszczyk, J. Kedziora, et al., Lodz/Poland

>> Back to Poster Session Overview >> Back to Programme Overview

German Society of Oto-Rhino-Laryngology, Head and Neck Surgery.
All contents copyright © 1998-1999. All rights reserved.

Contents Bernd Freigang, MD, Ph.D., Working Group "New Media"

HTML & Webdesign SPALLEK.COM
Technial Problems? Webmaster

Created: January 12th, 1998 Revised:

Even poster numbers:	Sunday	May 14, 2000	10.30 a.m. - 11.00 a.m.
	Monday	May 15, 2000	10.30 a.m. - 11.00 a.m.
	Tuesday	May 16, 2000	10.30 a.m. - 11.00 a.m.
	Wednesday	May 17, 2000	10.30 a.m. - 11.00 a.m.
Uneven poster numbers:	Sunday	May 14, 2000	4.00 p.m. - 4.30 p.m.
	Monday	May 15, 2000	4.00 p.m. - 4.30 p.m.
	Tuesday	May 16, 2000	4.00 p.m. - 4.30 p.m.
	Thursday	May 18, 2000	10.30 a.m. - 11.00 a.m.

Number	Title, Author
1432	The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus oncoprotein latent membrane protein 1 H. Takeshita, M. Furukawa, T. Yoshizaki, Kanazawa, Ishikawa/Japan
1433	Increased levels of urokinase receptor in plasma of head and neck squamous cell carcinoma patients M. Schmidt, F. Hoppe, Würzburg/Germany
1434	Immunostaining of nm23 and p53 antigens in metastasizing and nonmetastasizing laryngeal cancer T. Krecicki, D. Ous, J. Kozlak, Zalesska-Krecicka, Wroclaw/Poland
1435	Telomerase activity in head and neck squamous cell carcinoma C. Motsch, R.Schneider-Stock, Magdeburg/Germany
1436	Ultrastructural expression of E-cadherin in squamous cell carcinomas and cell lines Th. Stange, Th. Schrom, A. Berghaus, H.-J. Holzhausen, Halle /Germany
1437	Model for testing of cytostatic effects of different agents under hypoxic conditions on ENT-relevant tumor cells D.Matschiner, M. Bloching, H. Liedtke, Th. Stange, Halle/Germay
1438	Cytokine release of immune cells following stimulation with bispecific antibody BIU I A.Walz, R.Zeidler, B.Schmitt, H.Lindhofer, et al., Munich/Germany
1439	Genotoxicity of DI- and DIISO-Butylphthalates in human mucosal cells and lymphocytes B.C. Wallner, N. H. Kleinsasser, A. Bergner, U.A. Harréus, Munich/Germany
1440	Telomerase activity and inactivation of the tumor suppressor gene P16 (CDKN2A) in head and neck cancer S. Koscielny, R. Dahse, E. Beleites, W. Fiedler, Jena/Germany
1441	Prognostic significance of neovascularisation in laryngeal cancer W. Pietruzewska, H. Niewiadomska, M. Gryczynski, Lodz/Poland
1442	Expression of p53 and bcl-2 proteins in laryngeal cancer W. Pietruszewska, J. Kobos, M. Gryczynski, Lodz/Poland
1443	Is there an influence of ML-1 standardized mistletoe extract on IL-10 and IL-12 in patients with head and neck cancer? C. Fauser, M.K. Steuer-Vogt, R. Sedlmeier, V. Bonkowsky, Munich/Germany
1444	Human papillomavirus infection in the laryngeal carcinoma W. Makowska, E. Bogacka-Zatorska, T. Rogozinski, Warsaw/Poland
1445	Improved determination of carboplatin and docetaxel cytotoxicity R. Dollner, A. Dietz, H. Weidauer, C. Granzow, Heidelberg/Germany
1446	Apoptosis expression of P21 and P27 as a prognosis of squamous cell carcinoma of head and neck E.T. Becker, I. Wiest, M. K. Steuer-Vogt, H. P. Niedermeyer, Munich/Germany
1447	Syndecan-1 expression in laryngeal cancer J. Klatka, D. Skomra, W. Golabek, S. Klonowski, Lublin/Poland
1448	The expression of Ki 67 antigen in tracheal mucosa of patients with laryngeal malignomas D. Manestar, R. Starcevic, D. Kovac, I. Lustica, Rijeka/Croatia
1449	P53 allelic loss and the outcome of patients with squamous cell carcinoma of the head and neck C. Suarez, J. P. Rodrigo, V. Alvarez, Oviedo/Spain
1450	Evaluation of the activity of kininogene and kinins receptors in precancerous conditions as well in the head and neck area malignant neoplasms M. Kapral, U. Mazurek, T. Gierek, J. Pilch, Sosnowiec/Poland
1451	Antioxidant enzymatic activity in blood of patients with chronic hypertrophy of ORL organs and carcinoma of larynx P. Zalewski, J. Olszewski, J. Blaszczyk, J. Kedziora, et al., Lodz/Poland
>> Back to Poster Session Overview >> Back to Programme Overview